SORL1 and ovarian carcinoma: In ovarian cancer, one study reported that SORL1 can stabilize ATP-binding cassette subfamily member 1 (ABCB1, also known as multidrug resistance protein 1 or MDR1) to enhance resistance to cisplatin [9].